antihypertensive drugs have some value in the treatment of hypertension, but there is no unanimity on the indications for their use, and there are gaps in our knowledge of their effect on the natural history of the condition. Opinions vary from the highly critical to the enthusiastic. 'One needs only to look back at the past fifty years to be amazed and deeply concerned at the world-wide enthusiasm generated by many proposed therapies for hypertension which eventually met their well deserved doom-oblivion' (Goldring & Chasis, 1965 ). Yet others can say: 'The prognostic outlook for the patient with essential hypertension has changed dramatically during the past fifteen years' (Sokolow & Perloff, 1965) .
There is probably the least doubt about the value of drug therapy in the malignant phase. The 2-year survival rate without treatment is recorded as 1 per cent (Simpson & Gilchrist, 1958) ; 5 per cent (Kincaid-Smith et al., 1958) ; and 7 per cent (Leishman, 1959) . On drug treatment the corresponding figures for similar groups were 42 per cent (McMichael & Murphy, 1955) ; 40 per cent (Leishman, 1959) ; 33 per cent (Harington et al., 1959) . The clear diagnostic criteria for malignant hypertension, and the mortality figures quoted, have allowed most authorities to accept the value of treatment in this group (Pears & Pickering, 1965) . The death rate, however, is still formidable.
The less severe cases provide a more difficult problem of judgment. The main reason for this is the wide variation in the prognosis. For example, the 5-year survival rate in males with untreated non-malignant hypertension may be 56 per cent to 6 per cent (Simpson & Gilchrist, 1958) ; or 77 per cent to 28 per cent SCOTTISH MEDICAL JOURNAL GLASGOW APRIL 1966 (Smithwick, 1955 ; or 70 per cent to 20 per cent (Wagener & Keith, 1939) . How can one compare these results with a 55 per cent 5year survival in treated male hypertensives? (Hafkenschiel et al., 1965) . Most would still accept the grading of the optic fundal changes as a valuable guide to prognosis (Wagener & Keith, 1939) , though it is interesting that ophthalmologists seem now less keen on grading systems (Ballantyne & Michaelson, 1962) and an attempt to separate hypertensive from arteriosclerotic changes by a new grading scheme (Scheie, 1953) did not win general acceptance. Notwithstanding all these difficulties, there is still a good case for treating those with a substantial hypertension, particularly younger and middle-aged hypertensives with measurable cardiac involvement or more severe retinal changes (Shelburne, 1965) . Leishman (1959) found the mortality reduced to onethird of that in his untreated group, and commented on the reduction in fatal strokes. Smirk and Hodge (1963) report a reduction in deaths in both sexes from heart failure and stroke, and similar benefit was noted by Hamilton et al. (1964) .
Young patients with mildly elevated blood pressure form an unresolved therapeutic problem. Life insurance studies indicate that even a very mild elevation of blood pressure in a young male shortens, on average, his expectation of life (Brackenridge, 1962) .There is as yet no clinical trial proving that lifelong antihypertensive therapy improves this position, and most physicians probably take the view that therapy is not yet sufficiently trouble-free to advise it here.
There is relatively little to add to the list of available antihypertensive drugs since a previous annotation (Scottish Medical Journal, 1964) .Debrisoquin (Abrams et al., 1964; Moe et al., 1964) and alpha methyl tyrosine (Sjoerdsma et al., 1965) have not had sufficient trial to allow of mature assessment; and pargyline and bethanidine seem unlikely to displace guanethidine and methyl dopa, augmented when necessary by oral diuretics. In deciding on their own practice, clinicians are dependent on careful long-term studies of drug therapy, which frequently modify and temper the conclusions of initial publications.
Leading Articles
Such a study is that of Drs Dawson and Palmer, reported on page 113 of this issue of the Scottish Medical Journal. They conclude, as did Johnson et al. (1966) that methyl dopa is preferable to guanethidine on grounds of equal efficacy and fewer side-effects, and regard methyl dopa as the drug of first choice. Their series includes 24 patients with renal hypertension, and no difference was found between their response and that of the essential group. A favourable response can occur in renal hypertension even with initial moderate elevation of blood urea (Luke & Kennedy, 1964) but it seems probable that a gradual decline in renal function continues, even in well treated cases; treatment, however, may slow this decline (Lewis et al., 1965) and may be worthwhile except in the presence of gross renal failure.
Palmer and Dawson mention reports of hepatotoxic effects of guanoxan, noted by Cotton and Montuschi (1966) . It is too early as yet to assess the significance of these findings. Early reports of possible complications of drug therapy sometimes later appear to have been coincidental. Perhaps the report of 3 cases resembling polyarteritis during guanethidine therapy may be in that category (Dewar & Peaston, 1964) . However, since the completion of this paper by Dawson and Palmer, several cases of haemolytic anaemia and of positive Coombs'testswithoutanaemia have been reported in patients having methyl dopa (Carstairs et al., 1966; Cahal, 1966; Darnborough, 1966; Hayes, 1966) . At present the main need is for information on the frequency and significance of these findings. The future place of methyl dopa may turn on the results of such enquiries.
SEPTIC SHOCK
Most clinicians have seen a patient, either during an infective illness or following operation, suddenly collapse with rapid pulse, low blood and pulse pressure, oliguria and obviously poor peripheral circulation. The temperature may be elevated at the onset or become so later, and there is usually a history of a preceding chill or rigor. The patient may die in a few hours unresponsive to the usual therapeutic measures or, following an initial response, may collapse again and die. The most bewildering fact is that the cause of collapse may still be a mystery at the time of death and the clinician is left wondering-Why? Even at autopsy, the cause may be missed unless, by then, suspicion as to the presence of sepsis has been aroused.
This story, brief and tragic, is not as uncommon as was previously supposed and is dramatically illustrated once again on page 137 of this issue of the Scottish Medical Journal. Septic shock or bacteracmic shock, for such is the condition described, has been observed for over 50 years. But, even now, the mortality rate remains at over 50 per cent. It may be defined as a condition of hypotension, due Scot. med. J., 1966, 11: 145 to bacterial toxins and associated with a bacteraemia. Many organisms are involved: most commonly it is a Gram-negative septicaemia due to Escherichia coli but Proteus and Pseudomonas may occasionally be implicated. About one-third of cases are due to infection by Gram-positive organisms mainly staphylococci, less commonly streptococci, meningococci and clostridia.
It is obvious, from the organisms responsible, that the condition will be seen mainly after operations on the genito-urinary tract notably prostatectomy, and after infections or operations of a gynaecological or gastrointestinal nature especially if associated with peritonitis. Another source of organisms is the lung where Peterson and Krippaehne (1958) found unresolved infection in 26 of 32 patients who died from sepsis. Even in therapy there is danger where contaminated intravenous infusions have produced severe shock (Gilat et al., 1958) . Patients especially liable to septic shock are the old and debilitated either as a result of disease, operation or therapy with toxic drugs.
E. coli, which are probably the commonest organisms responsible for septic shock, have an endotoxin present in their wall which has manyeffects not all completely understood. Endotoxin shock produced by intravenous injection of the toxin from E. coli into dogs, has provided a model to study its effects. An initial increase in total peripheral resistance was observed due to vasospasm affecting the arterioles and venules (Lillehei et al., 1962) . This is produced in part by a direct action of the toxin plus possibly a formed element from the blood, and indirectly by release of large amounts of catecholamines (adrenaline and noradrenaline) from the adrenal (Rosenberg et al., 1959) . The rise in peripheral resistance is accompanied by a fall in cardiac output and blood flow through the viscera. In the dog, the intestine seems to suffer more than in man, with haemorrhages and necrosis of the intestinal mucosa. Vasospasm also results in stagnant anoxia of the capillary beds, blood cells may be trapped in the capillaries and plasma may leak therefrom. Tissue anoxia results in metabolic acidosis and this with local accumulation of histamine or plasma polypeptides (Thal & Sardesai,
